Cargando…

Adjuvant chemotherapy for soft-tissue sarcoma: review and meta-analysis of the published results of randomised clinical trials.

Fifteen published randomised trials comparing adjuvant chemotherapy with no chemotherapy in soft-tissue sarcoma (STS) were identified (1546 patients). A qualitative review and a meta-analysis of this published literature were performed. With the qualitative review it was not possible to synthesise t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tierney, J. F., Mosseri, V., Stewart, L. A., Souhami, R. L., Parmar, M. K.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1995
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034002/ https://www.ncbi.nlm.nih.gov/pubmed/7640234

Ejemplares similares

Adjuvant Chemotherapy of Soft Tissue Sarcoma—Current Status
por: Judson, Ian
Publicado: (2000)

Adjuvant chemotherapy in soft tissue sarcomas…Conflicts, consensus, and controversies
por: Bajpai, Jyoti, et al.
Publicado: (2016)

Long-Term Neurotoxicity of Chemotherapy in Adolescents and Young Adults Treated for Bone and Soft Tissue Sarcomas
por: Earl, Helena M., et al.
Publicado: (1998)

Neoadjuvant and adjuvant doxorubicin chemotherapy in a case of feline soft tissue sarcoma
por: Torrigiani, Filippo, et al.
Publicado: (2019)

Adjuvant chemotherapy for soft tissue sarcomas: a 10-year mono-institutional experience
por: Brunello, Antonella, et al.
Publicado: (2015)

Indian data on bone and soft tissue sarcomas: A summary of published study results
por: Ramaswamy, Anant, et al.
Publicado: (2016)

Adjuvant Chemotherapy Following Complete Resection of Soft Tissue Sarcoma in Adults: A Clinical Practice Guideline
por: Figueredo, Alvaro, et al.
Publicado: (2002)

Prognostic variables for the selection of patients with operable soft tissue sarcomas to be considered in adjuvant chemotherapy trials.
por: Ravaud, A., et al.
Publicado: (1992)

Adjuvant radiotherapy with brachytherapy boost in soft tissue sarcomas
por: Cortesi, Annalisa, et al.
Publicado: (2017)

Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial
por: Brodowicz, Thomas, et al.
Publicado: (2000)

Risk-stratified patients with resectable soft tissue sarcoma benefit from epirubicin-based adjuvant chemotherapy
por: Schenone, Aaron D, et al.
Publicado: (2014)

Adjuvant chemotherapy—Radiotherapy—Chemotherapy sandwich protocol in resectable soft tissue sarcoma: An updated single-center analysis of 104 cases
por: Schliemann, Christoph, et al.
Publicado: (2018)

Controversies and consensus of neoadjuvant chemotherapy in soft-tissue sarcomas
por: Loong, Herbert H., et al.
Publicado: (2018)

Results of resection of forearm soft tissue sarcoma
por: Nakata, Eiji, et al.
Publicado: (2023)

Chemotherapy for metastatic soft tissue sarcomas--another full circle?
por: Bramwell, V. H.
Publicado: (1991)

Efficacy of adjuvant radiotherapy in non-extremity soft tissue sarcoma with moderate chemosensitivity
por: Lee, Eun Mi, et al.
Publicado: (2018)

ASO Author Reflections: Benefit of Adjuvant Radiotherapy for Clinical Outcome in Patients with Soft Tissue Sarcoma
por: Haas, R. L., et al.
Publicado: (2018)

Assessing and improving the reliability of meta-analyses of hazard ratios derived from published time-to-event data
por: Tierney, Jayne, et al.
Publicado: (2013)

(Neo)adjuvant chemotherapy and interdigitated split-course hyperfractionated radiation in high risk soft tissue sarcoma – Results from a large single-institution series
por: Nevala, Riikka, et al.
Publicado: (2019)

Trabectedin in Soft Tissue Sarcomas
por: Petek, Bradley J., et al.
Publicado: (2015)

Clinical Benefit of Second-Line Palliative Chemotherapy in Advanced Soft-Tissue Sarcoma
por: Minchom, Anna, et al.
Publicado: (2010)

Soft-tissue Sarcomas
por: Vodanovich, Domagoj Ante, et al.
Publicado: (2018)

Risk factors for hematological toxicity of chemotherapy for bone and soft tissue sarcoma
por: OUYANG, ZHENGXIAO, et al.
Publicado: (2013)

Perspectives of Cell Sensitivity/Resistance Assay in Soft Tissue Sarcomas Chemotherapy
por: Fetisov, Timur I., et al.
Publicado: (2023)

Genomic complexity in pediatric synovial sarcomas (Synobio study): the European pediatric soft tissue sarcoma group (EpSSG) experience
por: Orbach, Daniel, et al.
Publicado: (2018)

Postirradiation Sarcoma: Clinicopathologic Features and Role of Chemotherapy in the Treatment Strategy
por: des Guetz, Gaetan, et al.
Publicado: (2009)

Surgical resection with adjuvant brachytherapy in soft tissue sarcoma of the extremity – a case report
por: Guzik, Grzegorz, et al.
Publicado: (2012)

Adjuvant high dose rate brachytherapy for soft tissue sarcomas: initial experience report
por: Bradley, Julie A., et al.
Publicado: (2011)

A phase II study evaluating neo-/adjuvant EIA chemotherapy, surgical resection and radiotherapy in high-risk soft tissue sarcoma
por: Schmitt, Thomas, et al.
Publicado: (2011)

Priorities and preferences of advanced soft tissue sarcoma patients starting palliative chemotherapy: baseline results from the HOLISTIC study
por: Younger, E., et al.
Publicado: (2021)

A Retrospective Analysis of Vinorelbine Chemotherapy for Patients With Previously Treated Soft-Tissue Sarcomas
por: Anderson, Sibyl E., et al.
Publicado: (2006)

PROMIS scores of patients undergoing neoadjuvant and adjuvant radiation therapy for surgically excised soft tissue sarcoma
por: Moon, T.M., et al.
Publicado: (2021)

Pazopanib in advanced soft tissue sarcomas
por: Lee, Alex T. J., et al.
Publicado: (2019)

Efficacy of Eribulin in Soft Tissue Sarcomas
por: Phillips, Edward, et al.
Publicado: (2022)

Oxaliplatin-dacarbazine combination chemotherapy for the treatment of advanced soft tissue sarcoma of the limbs
por: Zong, Xiang-Yun, et al.
Publicado: (2009)

First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma
por: Yousaf, Nadia, et al.
Publicado: (2015)

Neoadjuvant chemotherapy for radiation-associated soft-tissue sarcoma: A case report
por: Patel, Ronak, et al.
Publicado: (2019)

Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy
por: Virgili Manrique, Anna C., et al.
Publicado: (2022)

SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy
por: Davis, Elizabeth J., et al.
Publicado: (2016)

Retroperitoneal soft tissue sarcoma
por: Zepeda, Ernesto, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_lv7nrljf1pm9n7tipiiv1lalvl